A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.
Robert M. Hallock, Andrew Dean, Zachary A Knecht, Jared Spencer, Elise C Taverna
Drug and Alcohol Dependence June 1, 2013 DOI: 10.1016/j.drugalcdep.2012.11.010 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Survey Peer reviewed |
|---|---|
| Sample size | 409 |
| Population | Randomly selected undergraduates at Skidmore College in upstate New York |
| Key findings | 29.5% of surveyed college students reported psilocybin mushroom use, with users and non-users differing significantly in perceptions of the drug's addictiveness and potential for abuse. |
Abstract
Recreational usage and attitudes toward psilocybin-containing hallucinogenic mushrooms among college students are seldom explored. We surveyed 882 randomly selected undergraduates at Skidmore College in upstate New York and quantified whether participants had ever used psilocybin mushrooms, their attitudes toward the drug, and polydrug use. There were 409 responses and 29.5% of the sample reported psilocybin use. Among users, the mean number of times they reported using mushrooms was 3.4 (mode=1). The top factors cited that influenced their decisions to try hallucinogenic mushrooms for the first time were 'curiosity', 'to achieve a mystical experience', and 'introspection'. Users and non-users had significantly different perceptions of mushrooms: non-users were more likely to say that hallucinogenic mushrooms were addictive and had the potential for abuse than users. Users did not believe that psilocybin negatively impacts their academics, mental health, or physical health, while non-users did. Both users and non-users of psilocybin reported high life-time use of alcohol (97% vs 96%, respectively), marijuana (98% vs 73%, respectively) and tobacco (82% vs 54%, respectively). Psilocybin users were significantly more likely to use other drugs such as cocaine, ecstasy, opiates, non-prescribed prescription drugs, opiates, and lysergic acid diethylamide (LSD) than non-users of psilocybin. This study uncovers important insights into hallucinogenic mushroom use by college students.
Citations in the library
Cited by 28
- Psychedelics and Mental Health: A Population Study PLoS One August 19, 2013
- Psychedelics not linked to mental health problems or suicidal behavior: A population study Journal of Psychopharmacology March 1, 2015
- Over 30 million psychedelic users in the United States F1000Research March 28, 2013
- Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study European Neuropsychopharmacology October 17, 2020
- Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers. Journal of Psychopharmacology February 28, 2019
and 23 more in the library
Cites 7
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- The pharmacology of psilocybin Addiction Biology October 1, 2002
- Patterns of simultaneous polysubstance use in drug using university students Human Psychopharmacology: Clinical and Experimental June 1, 2006
and 2 more in the library